Berkeley Lights, Inc. (BLI) specializes in developing and commercializing advanced technology platforms for cell analysis and manipulation, particularly in the areas of cell therapy, antibody discovery, and synthetic biology. The company generates revenue by selling their proprietary platforms, such as the Beacon and Lightning systems, as well as offering related services and consumables to biotechnology and pharmaceutical companies for research and development purposes.